PFIZER INC

NYSE: PFE (Pfizer, Inc.)

最近更新时间: 3小时之前

24.70

0.16 (0.65%)

前收盘价格 24.54
收盘价格 24.50
成交量 39,236,224
平均成交量 (3个月) 45,675,070
市值 140,084,822,016
市盈率 (P/E TTM) 17.52
预期市盈率 (P/E Forward) 8.35
价格/销量 (P/S) 2.20
股市价格/股市净资产 (P/B) 1.58
52周波幅
24.31 (-1%) — 31.54 (27%)
利润日期 29 Apr 2025
股息率 (DY TTM) 6.84%
营业毛利率 12.62%
营业利益率 (TTM) 15.90%
稀释每股收益 (EPS TTM) 1.41
季度收入增长率 (YOY) 21.90%
季度盈利增长率 (YOY) -98.20%
总债务/股东权益 (D/E MRQ) 76.18%
流动比率 (MRQ) 1.17
营业现金流 (OCF TTM) 12.74 B
杠杆自由现金流 (LFCF TTM) 12.78 B
资产报酬率 (ROA TTM) 4.64%
股东权益报酬率 (ROE TTM) 9.06%

市场趋势

短期 中期
行业 Drug Manufacturers - General (US) 混合的 看涨
Drug Manufacturers - General (全球的) 混合的 看涨
股票 Pfizer, Inc. 看跌 看跌

AIStockmoo 评分

0.8
分析师共识 3.0
内部交易活动 NA
价格波动 1.5
技术平均移动指标 1.0
技术振荡指标 -2.5
平均 0.75

相关股票

股票 市值 DY P/E(TTM) P/B
PFE 140 B 6.84% 17.52 1.58
JNJ 374 B 3.19% 26.83 5.50
ABBV 367 B 3.03% 87.24 109.22
BMY 122 B 4.03% - 7.64
GSK 70 B 4.54% 23.00 4.47
LLY 735 B 0.66% 70.05 52.04

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

部门 Healthcare
行业 Drug Manufacturers - General
投资方式 Large Value
内部持股比例 0.06%
机构持股比例 67.48%
52周波幅
24.31 (-1%) — 31.54 (27%)
目标价格波幅
29.00 (17%) — 33.00 (33%)
33.00 (Guggenheim, 33.60%) 购买
29.00 (17.41%)
29.00 (UBS, 17.41%) 保留
29.00 (Citigroup, 17.41%) 保留
平均值 30.33 (22.79%)
总计 1 购买, 2 保留
平均价格@调整类型 26.49
公司 日期 目标价格 调整类型 价格@调整类型
Guggenheim 10 Feb 2025 33.00 (33.60%) 购买 25.87
Citigroup 28 Jan 2025 29.00 (17.41%) 保留 26.75
UBS 08 Jan 2025 29.00 (17.41%) 保留 26.86

该时间范围内无数据。

日期 类型 细节
01 Apr 2025 公告 European Commission Approves Pfizer’s RSV Vaccine ABRYSVO® to Help Protect Adults Aged 18-59 Against RSV Lower Respiratory Tract Disease
31 Mar 2025 CNBC Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.
24 Mar 2025 CNBC Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
18 Mar 2025 公告 Pfizer Invites Public to View and Listen to Webcast of April 29 Conference Call with Analysts
11 Mar 2025 公告 Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial
24 Feb 2025 公告 Summit Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Ivonescimab in Combination with Pfizer Antibody Drug Conjugates (ADCs)
24 Feb 2025 公告 Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
24 Feb 2025 公告 Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs
21 Feb 2025 CNBC Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
13 Feb 2025 公告 Pfizer’s TALZENNA® in Combination with XTANDI® Improves Survival Outcomes in Metastatic Castration Resistant Prostate Cancer
12 Feb 2025 公告 U.S. FDA Approves Pfizer’s ADCETRIS® Combination Regimen for the treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
10 Feb 2025 公告 Pfizer and Astellas’ PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) Shows Long-Term Efficacy in First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer (la/mUC)
10 Feb 2025 CNBC Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
06 Feb 2025 CNBC Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
04 Feb 2025 CNBC Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off
04 Feb 2025 CNBC Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary 
04 Feb 2025 公告 Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance
03 Feb 2025 公告 Pfizer’s BRAFTOVI® Combination Regimen Significantly Improved Progression-Free Survival and Overall Survival in Phase 3 BREAKWATER Trial
28 Jan 2025 公告 Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
27 Jan 2025 CNBC Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
27 Jan 2025 公告 Telescope Innovations Presents Results of First Fiscal Quarter 2025
25 Jan 2025 公告 Pfizer’s BRAFTOVI® Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
17 Jan 2025 CNBC Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
10 Jan 2025 公告 Pfizer’s Sasanlimab in Combination with BCG Improves Event-Free Survival in Patients with BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer
06 Jan 2025 公告 Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
02 Jan 2025 TheEdge Estee Lauder, Pfizer, Nike in Morningstar’s list of 10 cheapest wide-moat US stocks
显示更多
股息率 (DY TTM) 6.84%
5年平均股息收益率 4.38%
股息支付比率 119.15%
预计下次股息支付 Sep 2025
除息日 公告日期 支付日期 详情
24 Jan 2025 12 Dec 2024 07 Mar 2025 0.43 现金
08 Nov 2024 09 Oct 2024 02 Dec 2024 0.42 现金
26 Jul 2024 26 Jun 2024 03 Sep 2024 0.42 现金
09 May 2024 24 Apr 2024 14 Jun 2024 0.42 现金
25 Jan 2024 14 Dec 2023 01 Mar 2024 0.42 现金
09 Nov 2023 04 Oct 2023 04 Dec 2023 0.41 现金
27 Jul 2023 22 Jun 2023 05 Sep 2023 0.41 现金
11 May 2023 26 Apr 2023 09 Jun 2023 0.41 现金
26 Jan 2023 09 Dec 2022 03 Mar 2023 0.41 现金
03 Nov 2022 22 Sep 2022 05 Dec 2022 0.4 现金
28 Jul 2022 23 Jun 2022 06 Sep 2022 0.4 现金
12 May 2022 28 Apr 2022 10 Jun 2022 0.4 现金
27 Jan 2022 10 Dec 2021 04 Mar 2022 0.4 现金
04 Nov 2021 23 Sep 2021 06 Dec 2021 0.39 现金
29 Jul 2021 24 Jun 2021 07 Sep 2021 0.39 现金
06 May 2021 22 Apr 2021 04 Jun 2021 0.39 现金
28 Jan 2021 11 Dec 2020 05 Mar 2021 0.39 现金
05 Nov 2020 24 Sep 2020 01 Dec 2020 0.38 现金
30 Jul 2020 25 Jun 2020 01 Sep 2020 0.38 现金
07 May 2020 23 Apr 2020 05 Jun 2020 0.38 现金
30 Jan 2020 16 Dec 2019 06 Mar 2020 0.38 现金
07 Nov 2019 24 Sep 2019 02 Dec 2019 0.36 现金
01 Aug 2019 28 Jun 2019 03 Sep 2019 0.36 现金
09 May 2019 26 Apr 2019 07 Jun 2019 0.36 现金
31 Jan 2019 15 Dec 2018 01 Mar 2019 0.36 现金
08 Nov 2018 28 Sep 2018 03 Dec 2018 0.34 现金
02 Aug 2018 29 Jun 2018 04 Sep 2018 0.34 现金
10 May 2018 26 Apr 2018 01 Jun 2018 0.34 现金
01 Feb 2018 18 Dec 2017 01 Mar 2018 0.34 现金
09 Nov 2017 27 Sep 2017 01 Dec 2017 0.32 现金
02 Aug 2017 22 Jun 2017 01 Sep 2017 0.32 现金
10 May 2017 27 Apr 2017 01 Jun 2017 0.32 现金
01 Feb 2017 12 Dec 2016 01 Mar 2017 0.32 现金
08 Nov 2016 22 Sep 2016 01 Dec 2016 0.3 现金
03 Aug 2016 23 Jun 2016 01 Sep 2016 0.3 现金
11 May 2016 28 Apr 2016 01 Jun 2016 0.3 现金
03 Feb 2016 14 Dec 2015 02 Mar 2016 0.3 现金
04 Nov 2015 25 Sep 2015 01 Dec 2015 0.28 现金
05 Aug 2015 25 Jun 2015 02 Sep 2015 0.28 现金
06 May 2015 23 Apr 2015 02 Jun 2015 0.28 现金
04 Feb 2015 14 Dec 2014 03 Mar 2015 0.28 现金
05 Nov 2014 23 Oct 2014 02 Dec 2014 0.26 现金
30 Jul 2014 26 Jun 2014 03 Sep 2014 0.26 现金
07 May 2014 24 Apr 2014 03 Jun 2014 0.26 现金
05 Feb 2014 16 Dec 2013 04 Mar 2014 0.26 现金
06 Nov 2013 24 Oct 2013 03 Dec 2013 0.24 现金
31 Jul 2013 27 Jun 2013 04 Sep 2013 0.24 现金
08 May 2013 25 Apr 2013 04 Jun 2013 0.24 现金
30 Jan 2013 17 Dec 2012 05 Mar 2013 0.24 现金
07 Nov 2012 25 Oct 2012 04 Dec 2012 0.22 现金
01 Aug 2012 28 Jun 2012 05 Sep 2012 0.22 现金
09 May 2012 26 Apr 2012 05 Jun 2012 0.22 现金
01 Feb 2012 12 Dec 2011 06 Mar 2012 0.22 现金
08 Nov 2011 27 Oct 2011 06 Dec 2011 0.2 现金
03 Aug 2011 23 Jun 2011 06 Sep 2011 0.2 现金
11 May 2011 28 Apr 2011 07 Jun 2011 0.2 现金
02 Feb 2011 13 Dec 2010 01 Mar 2011 0.2 现金
04 Nov 2010 28 Oct 2010 01 Dec 2010 0.18 现金
04 Aug 2010 24 Jun 2010 01 Sep 2010 0.18 现金
05 May 2010 22 Apr 2010 01 Jun 2010 0.18 现金
03 Feb 2010 14 Dec 2009 02 Mar 2010 0.18 现金
04 Nov 2009 22 Oct 2009 01 Dec 2009 0.16 现金
05 Aug 2009 25 Jun 2009 02 Sep 2009 0.16 现金
06 May 2009 23 Apr 2009 02 Jun 2009 0.16 现金
04 Feb 2009 15 Dec 2008 03 Mar 2009 0.32 现金
05 Nov 2008 23 Oct 2008 02 Dec 2008 0.32 现金
06 Aug 2008 26 Jun 2008 03 Sep 2008 0.32 现金
07 May 2008 24 Apr 2008 03 Jun 2008 0.32 现金
06 Feb 2008 17 Dec 2007 04 Mar 2008 0.32 现金
07 Nov 2007 25 Oct 2007 04 Dec 2007 0.29 现金
08 Aug 2007 28 Jun 2007 05 Sep 2007 0.29 现金
09 May 2007 26 Apr 2007 05 Jun 2007 0.29 现金
07 Feb 2007 18 Dec 2006 06 Mar 2007 0.29 现金
08 Nov 2006 26 Oct 2006 05 Dec 2006 0.24 现金
09 Aug 2006 22 Jun 2006 05 Sep 2006 0.24 现金
10 May 2006 27 Apr 2006 06 Jun 2006 0.24 现金
08 Feb 2006 12 Dec 2005 07 Mar 2006 0.24 现金
08 Nov 2005 27 Oct 2005 06 Dec 2005 0.19 现金
10 Aug 2005 23 Jun 2005 06 Sep 2005 0.19 现金
11 May 2005 28 Apr 2005 07 Jun 2005 0.19 现金
09 Feb 2005 13 Dec 2004 08 Mar 2005 0.19 现金
09 Nov 2004 28 Oct 2004 03 Dec 2004 0.17 现金
11 Aug 2004 24 Jun 2004 03 Sep 2004 0.17 现金
12 May 2004 22 Apr 2004 04 Jun 2004 0.17 现金
11 Feb 2004 15 Dec 2003 05 Mar 2004 0.17 现金
12 Nov 2003 23 Oct 2003 04 Dec 2003 0.15 现金
13 Aug 2003 26 Jun 2003 04 Sep 2003 0.15 现金
14 May 2003 24 Apr 2003 05 Jun 2003 0.15 现金
15 Jan 2003 16 Dec 2002 14 Feb 2003 0.15 现金
13 Nov 2002 24 Oct 2002 05 Dec 2002 0.13 现金
14 Aug 2002 27 Jun 2002 05 Sep 2002 0.13 现金
15 May 2002 25 Apr 2002 06 Jun 2002 0.13 现金
13 Feb 2002 18 Dec 2001 07 Mar 2002 0.13 现金
14 Nov 2001 25 Oct 2001 06 Dec 2001 0.11 现金
15 Aug 2001 28 Jun 2001 06 Sep 2001 0.11 现金
16 May 2001 26 Apr 2001 07 Jun 2001 0.11 现金
14 Feb 2001 18 Dec 2000 08 Mar 2001 0.11 现金
15 Nov 2000 26 Oct 2000 07 Dec 2000 0.09 现金
16 Aug 2000 22 Jun 2000 07 Sep 2000 0.09 现金
16 Aug 2000 01 Jun 2000 15 Sep 2000 0.09 现金
09 May 2000 27 Apr 2000 08 Jun 2000 0.09 现金
16 Feb 2000 13 Dec 1999 09 Mar 2000 0.09 现金
09 Nov 1999 28 Oct 1999 09 Dec 1999 0.08 现金
04 Aug 1999 24 Jun 1999 09 Sep 1999 0.08 现金
05 May 1999 22 Apr 1999 10 Jun 1999 0.22 现金
10 Feb 1999 14 Dec 1998 11 Mar 1999 0.22 现金
04 Nov 1998 22 Oct 1998 10 Dec 1998 0.19 现金
05 Aug 1998 25 Jun 1998 10 Sep 1998 0.19 现金
06 May 1998 23 Apr 1998 11 Jun 1998 0.19 现金
04 Feb 1998 22 Jan 1998 12 Mar 1998 0.19 现金
05 Nov 1997 23 Oct 1997 11 Dec 1997 0.17 现金
30 Jul 1997 26 Jun 1997 11 Sep 1997 0.17 现金
07 May 1997 24 Apr 1997 12 Jun 1997 0.34 现金
05 Feb 1997 23 Jan 1997 13 Mar 1997 0.34 现金
06 Nov 1996 24 Oct 1996 12 Dec 1996 0.3 现金
31 Jul 1996 27 Jun 1996 12 Sep 1996 0.3 现金
08 May 1996 25 Apr 1996 13 Jun 1996 0.3 现金
07 Feb 1996 25 Jan 1996 14 Mar 1996 0.3 现金
08 Nov 1995 26 Oct 1995 21 Dec 1995 0.26 现金
02 Aug 1995 22 Jun 1995 21 Sep 1995 0.26 现金
08 May 1995 27 Apr 1995 15 Jun 1995 0.52 现金
06 Feb 1995 26 Jan 1995 16 Mar 1995 0.52 现金
04 Nov 1994 27 Oct 1994 15 Dec 1994 0.47 现金
01 Aug 1994 23 Jun 1994 15 Sep 1994 0.47 现金
09 May 1994 28 Apr 1994 16 Jun 1994 0.47 现金
07 Feb 1994 27 Jan 1994 17 Mar 1994 0.47 现金
05 Nov 1993 28 Oct 1993 16 Dec 1993 0.42 现金
02 Aug 1993 25 Jun 1993 16 Sep 1993 0.42 现金
10 May 1993 22 Apr 1993 17 Jun 1993 0.42 现金
08 Feb 1993 28 Jan 1993 18 Mar 1993 0.42 现金
16 Nov 1992 22 Oct 1992 17 Dec 1992 0.37 现金
03 Aug 1992 25 Jun 1992 17 Sep 1992 0.37 现金
11 May 1992 23 Apr 1992 18 Jun 1992 0.37 现金
03 Feb 1992 23 Jan 1992 19 Mar 1992 0.37 现金
08 Nov 1991 24 Oct 1991 19 Dec 1991 0.33 现金
01 Aug 1991 27 Jun 1991 19 Sep 1991 0.33 现金
13 May 1991 25 Apr 1991 20 Jun 1991 0.33 现金
22 Feb 1991 24 Jan 1991 21 Mar 1991 0.66 现金
09 Nov 1990 25 Oct 1990 20 Dec 1990 0.6 现金
06 Aug 1990 28 Jun 1990 20 Sep 1990 0.6 现金
14 May 1990 26 Apr 1990 21 Jun 1990 0.6 现金
05 Feb 1990 25 Jan 1990 22 Mar 1990 0.6 现金
13 Nov 1989 26 Oct 1989 21 Dec 1989 0.55 现金
24 Jul 1989 22 Jun 1989 21 Sep 1989 0.55 现金
15 May 1989 27 Apr 1989 21 Jun 1989 0.55 现金
23 Jan 1989 19 Dec 1988 22 Mar 1989 0.55 现金
15 Nov 1988 27 Oct 1988 20 Dec 1988 0.5 现金
25 Jul 1988 23 Jun 1988 20 Sep 1988 0.5 现金
16 May 1988 28 Apr 1988 20 Jun 1988 0.5 现金
12 Feb 1988 28 Jan 1988 21 Mar 1988 0.5 现金
16 Nov 1987 22 Oct 1987 21 Dec 1987 0.45 现金
27 Jul 1987 25 Jun 1987 21 Sep 1987 0.45 现金
显示更多

每年股息收益率

年份 每年总股息 ($) 频率/年份 收益率 %
2025 0.430 1 1.74
2024 1.68 4 6.33
2023 1.64 4 5.70
2022 1.60 4 3.12
2021 1.56 4 2.64
2020 1.52 4 4.13
2019 1.44 4 3.87
2018 1.36 4 3.28
2017 1.28 4 3.73
2016 1.20 4 3.89
2015 1.12 4 3.66
2014 1.04 4 3.52
2013 0.960 4 3.30
2012 0.880 4 3.70
2011 0.800 4 3.90
2010 0.720 4 4.33
2009 0.800 4 4.64
2008 1.28 4 7.62
2007 1.16 4 5.38
2006 0.960 4 3.91
2005 0.760 4 3.44
2004 0.680 4 2.67
2003 0.600 4 1.79
2002 0.520 4 1.79
2001 0.440 4 1.16
2000 0.450 5 1.03
1999 0.600 4 1.95
1998 0.760 4 1.92
1997 1.02 4 4.33
1996 1.20 4 9.14
1995 1.56 4 15.66
1994 1.88 4 30.78
1993 1.68 4 30.80
1992 1.48 4 25.82
1991 1.65 4 24.84
1990 2.40 4 75.18
1989 2.20 4 80.07
1988 2.00 4 87.23
1987 0.900 2 48.83
显示更多

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2025 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票